Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.18
+0.04 (0.78%)
Mar 17, 2026, 8:00 AM EDT - Market open
Sagimet Biosciences Employees
Sagimet Biosciences had 14 employees as of December 31, 2024. The number of employees increased by 4 or 40.00% compared to the previous year.
Employees
14
Change (1Y)
4
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$3,645,571
Market Cap
168.79M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 14 | 4 | 40.00% | 14 | 0 |
| Dec 31, 2023 | 10 | 0 | - | 8 | 2 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2020 | 7 | - | - | 6 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| Nkarta | 105 |
| Caribou Biosciences | 97 |
| Tonix Pharmaceuticals Holding | 81 |
| Evaxion | 46 |
| Milestone Pharmaceuticals | 33 |
| Eledon Pharmaceuticals | 31 |
| Corbus Pharmaceuticals Holdings | 28 |
SGMT News
- 6 days ago - Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 13 days ago - Sagimet Biosciences Inc. (SGMT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript - Seeking Alpha
- 20 days ago - Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Sagimet Announces Positive 52-Week Data from License Partner Ascletis' Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne - GlobeNewsWire
- 6 weeks ago - Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne - PRNewsWire
- 7 weeks ago - Biotech Veteran and Virologist Joins CancerVax as Senior Scientific Advisor - GlobeNewsWire
- 2 months ago - Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference - GlobeNewsWire